We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.39B
AUM Growth
-$206M
Cap. Flow
+$24.9M
Cap. Flow %
0.57%
Top 10 Hldgs %
31.12%
Holding
1,194
New
99
Increased
241
Reduced
259
Closed
119

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$25.6M
2
PXD
Pioneer Natural Resource Co.
PXD
+$12.2M
3
HD icon
Home Depot
HD
+$11.6M
4
LHX icon
L3Harris
LHX
+$10.3M
5
GNRC icon
Generac Holdings
GNRC
+$8.99M

Top Sells

Rank Stock Value
1
EXPD icon
Expeditors International
EXPD
+$21.2M
2
DHI icon
D.R. Horton
DHI
+$14.1M
3
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$13M
4
AZO icon
AutoZone
AZO
+$11.3M
5
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 26.98%
2 Healthcare 19.12%
3 Financials 13.19%
4 Industrials 9.29%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WWE
901
DELISTED
World Wrestling Entertainment
WWE
$6K ﹤0.01%
100
– –
ARNC
902
DELISTED
Arconic Corporation
ARNC
$6K ﹤0.01%
205
+25
+14% +$743
DS
903
DELISTED
Drive Shack Inc.
DS
$6K ﹤0.01%
+4,000
New +$5.43K
ATKR icon
904
Atkore
ATKR
$2.59B
$5K ﹤0.01%
51
– –
FABC
905
Fabric.AI Inc
FABC
$16.8M
$5K ﹤0.01%
30
– –
BLUE
906
DELISTED
bluebird bio
BLUE
$5K ﹤0.01%
50
– –
CNC icon
907
Centene
CNC
$31.3B
$5K ﹤0.01%
+56
New +$4.59K
CRSP icon
908
CRISPR Therapeutics
CRSP
$4.58B
$5K ﹤0.01%
80
– –
DSGX icon
909
Descartes Systems
DSGX
$5.84B
$5K ﹤0.01%
74
– –
EXPE icon
910
Expedia Group
EXPE
$31.2B
$5K ﹤0.01%
26
-30
-54% -$5.61K
FSLR icon
911
First Solar
FSLR
$21.8B
$5K ﹤0.01%
60
– –
GSAT icon
912
Globalstar
GSAT
$10.2B
$5K ﹤0.01%
249
– –
HXL icon
913
Hexcel
HXL
$8.32B
$5K ﹤0.01%
+92
New +$5.07K
IEF icon
914
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$5K ﹤0.01%
+46
New +$5.11K
NTLA icon
915
Intellia Therapeutics
NTLA
$1.5B
$5K ﹤0.01%
65
– –
SITE icon
916
SiteOne Landscape Supply
SITE
$4.43B
$5K ﹤0.01%
28
– –
SPYM
917
State Street SPDR Portfolio S&P 500 ETF
SPYM
$158B
$5K ﹤0.01%
+89
New +$4.66K
WAL icon
918
Western Alliance Bancorporation
WAL
$9.07B
$5K ﹤0.01%
58
– –
MTTR
919
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$5K ﹤0.01%
+600
New +$5.68K
AFRM icon
920
Affirm
AFRM
$23.5B
$4K ﹤0.01%
84
-364
-81% -$19K
ASAN icon
921
Asana
ASAN
$1.58B
$4K ﹤0.01%
100
-265
-73% -$13.8K
CHWY icon
922
Chewy
CHWY
$8.54B
$4K ﹤0.01%
100
-200
-67% -$9.09K
DGT icon
923
State Street SPDR Global Dow ETF
DGT
$607M
$4K ﹤0.01%
36
– –
EDIT icon
924
Editas Medicine
EDIT
$399M
$4K ﹤0.01%
210
– –
ESOA icon
925
Energy Services of America
ESOA
$297M
$4K ﹤0.01%
+1,276
New +$4.06K
35 36
37
38 39

Similar funds

AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
SP
SIH Partners Wilmington, Delaware $7.58B AUM 5.28% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return

HM Payson & Co's Q1 2022 Portfolio in Review

As of Q1 2022, HM Payson & Co held 1,194 positions worth $4.39B, down 4.5% from $4.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

HM Payson & Co's Q1 2022 filing shows 99 new, 241 increased, 259 reduced and 119 closed positions. Its largest new stake was Standex International: 6,344 shares worth $634K. The largest sale was Expeditors International, an estimated $21.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q1 2022 buy was Standex International: 6,344 shares worth $634K.
  • HM Payson & Co added most to Bristol-Myers Squibb in Q1 2022, an estimated $25.6M increase.
  • HM Payson & Co's biggest Q1 2022 reduction was Expeditors International, cutting an estimated $21.2M.
  • HM Payson & Co fully exited Vanguard Ultra-Short Bond ETF in Q1 2022, selling an estimated $3.01M.
  • HM Payson & Co's ten largest holdings make up 31% of its $4.39B portfolio in Q1 2022.
  • HM Payson & Co opened 99 new positions and closed 119 in Q1 2022.
  • HM Payson & Co's portfolio value fell 4.5% quarter-over-quarter to $4.39B.

Based on HM Payson & Co's 13F filing for Q1 2022, filed 12 May 2022.